Coronavirus infections are neuroinvasive and can provoke injury to the central nervous
system (CNS) and long-term illness consequences. They may be associated with …

Alzheimer's disease (AD) and COVID-19 share many common risk factors, such as
advanced age, complications, APOE genotype, etc. Epidemiological studies have also …

The COVID-19 outbreak caused by SARS-CoV-2 in late 2019 has spread rapidly across the
world to form a global epidemic of respiratory infectious diseases. Increased investigations …

Cyclic-AMP-response element-binding protein (CREB) is a leucine zipper class transcription
factor that is activated through phosphorylation. Ample CREB phosphorylation is required for …

Background The neurological effects of the coronavirus disease of 2019 (COVID-19) raise
concerns about potential long-term consequences, such as an increased risk of Alzheimer's …

Long COVID, also called post-acute sequelae of SARS-CoV-2, is characterized by a
multitude of lingering symptoms, including impaired cognition, that can last for many months …

OBJECTIVE: The pandemic of Coronavirus Disease 2019 (COVID-19) caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues, and SARS-CoV-2 …

Enabling challenging applications of nanomedicine and precision medicine in the treatment
of neurodegenerative disorders requires deeper investigations of nanocarrier-mediated …

This scoping review aimed to summarise the effects of the ketone body β-hydroxybutyrate.
The review details the revealed pathways and functional properties following its intervention …

Alzheimer's disease (AD) and prostate cancer (PCa) are considered the leading causes of
death in elderly people worldwide. Although both these diseases have striking differences in …